ArticleImmunity2020
Transcriptional and Functional Analysis of CD1c
Open access · hybridAbstract read
In one paragraph
Article in Immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 231 papers.
0numbers the graph read from it
0cells of the map it votes in
231citing papers in PubMed
16.2field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
231 citing papers in PubMed, 336 citations in OpenAlex.
- Impaired function and delayed regeneration of dendritic cells in COVID-19.PLoS pathogens · 2021Trial
- NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cells.Oncoimmunology · 2026Article
- Langerhans cell histiocytosis: molecular mechanisms underlying pathogenesis and emerging targeted therapeutics.Cancer metastasis reviews · 2026Review
- Comparative Transcriptomic Analysis Reveals Shared Interferon-Associated Transcriptional Programs and Subset-Associated Immune Variation in Human cDC1 and cDC2 Cells Following TLR7 Activation.Cell biochemistry and biophysics · 2026Article
- Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1ciScience · 2026Article
- Clonal lineage tracing of innate immune cells in human cancer.Cancer cell · 2026Article
- Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers.Annals of the rheumatic diseases · 2026Article
- Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.Nature communications · 2026Article
- Pan-cancer single-cell atlases of mouse and human tumor-associated dendritic cells.Nature communications · 2026Article
- Mechanical licensing of functional dendritic cell states for enhanced T cell priming.bioRxiv : the preprint server for biology · 2026Article
- Dendritic cells as orchestrators in the allergen-specific immunotherapy of allergic diseases.Clinical reviews in allergy & immunology · 2026Review
- Feeder-free generation of functional dendritic cells from human pluripotent stem cells.Journal for immunotherapy of cancer · 2026Article
- Tissue-resident memory T cells in organ transplantation: implications for immune homeostasis and graft outcomes.Inflammation and regeneration · 2026Review
- Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.JCI insight · 2026Article
- Accumulation of Siglec10European journal of immunology · 2026Article
- Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Tumors located in the brain impair the frequency and phenotype of dendritic cells in blood and tumor.iScience · 2026Article
- The transcription factor EHF promotes the maturation and immunosuppression of conventional dendritic cells.Nature communications · 2026Article
- Single-cell analysis of the peripheral immune landscape in Parkinson's disease: insights into dendritic cell and CD4+ T-cell transcriptomics.NPJ Parkinson's disease · 2026Article
- Spatial immune hubs defined by conserved activated dendritic cells are remodeled by immunotherapy.bioRxiv : the preprint server for biology · 2026Article
171 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
16 authors at 8 institutions in 3 countries.
Pierre BourdelyCentre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK.
Giorgio AnselmiCentre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK.
Kristine VaivodeCentre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK.
Rodrigo Nalio RamosPSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France.
Yoann Missolo-KoussouPSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France.
Sofia HidalgoPSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France; Laboratory of Immuno-oncology, Fundación Ciencia & Vida, Santiago, Chile.
Jimena TosseloPSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France.
Nicolas NuñezPSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France.
Wilfrid RicherPSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France.
Anne Vincent-SalomonPSL Research University, Institut Curie, Department of Biopathology, Paris, France.
Alka SaxenaNational Institute of Health Research Biomedical Research Centre at Guy's and St Thomas' Hospital and King's College London, London, UK.
Kristie WoodNational Institute of Health Research Biomedical Research Centre at Guy's and St Thomas' Hospital and King's College London, London, UK.
Alvaro LladserLaboratory of Immuno-oncology, Fundación Ciencia & Vida, Santiago, Chile; Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile.
Eliane PiaggioPSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France.
Julie HelftPSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France.
Pierre GuermonprezCentre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK; Université de Paris, Centre for Inflammation Research, CNRS ERL8252, INSERM1149 Paris, France. Electronic address: pierre.guermonprez@kcl.ac.uk.
Institut Curie · FRInserm · FRKing's College London · GBSt Thomas' Hospital · GBCentre de Recherche sur l'Inflammation · FRFundación Ciencia and Vida · CLKings Health Partners · GBUniversité Paris Sciences et Lettres · FR
Funding
Biotechnology and Biological Sciences Research CouncilCancer Research UK 22369Department of HealthNational Centre for the Replacement, Refinement and Reduction of Animals in Research NC/K001868/1
Abstract
Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation. In humans, the diversity, ontogeny, and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88
Indexed as
AnimalsAntigens, CDAntigens, CD1Antigens, Differentiation, MyelomonocyticBreast NeoplasmsCD163 AntigenCD8 AntigensCD8-Positive T-LymphocytesCell DifferentiationCell Line, TumorDendritic Cellsfms-Like Tyrosine Kinase 3GlycoproteinsGranulocyte-Macrophage Colony-Stimulating FactorHumansIntegrin alpha Chainsalpha E integrinsAntigens, CDAntigens, CD1Antigens, Differentiation, MyelomonocyticCD163 AntigenCD1C protein, humanCD8 AntigensCSF2 protein, humanFLT3 protein, humanfms-Like Tyrosine Kinase 3GlycoproteinsGranulocyte-Macrophage Colony-Stimulating FactorIntegrin alpha ChainsReceptors, Cell SurfaceTGFB1 protein, humanTransforming Growth Factor beta1cDC2sconventional DCsDC3sDC progenitorsinflammatory DCsmonocytesmononuclear phagocytesT(RM)
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.